Skip to content
Home/Companies/Biotech/Xpress Biologics
XB

Xpress Biologics

Biotech·Belgium·Exited 2022·Held 1yr

Xpress Biologics is a life science tools & biologic services company, headquartered in Belgium.

Entry
2021
Hold
1yr
Exit
2022
Est. EV
–

Who owns Xpress Biologics?

Xpress Biologics was owned by ARCHIMED through MED III (2021 vintage) from 2021 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED III · 2021 · Buyout

Key facts

HQBelgium
SectorLife Science Tools & Biologic Services
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from MED III

Other portfolio companies in the same fund.

BioVendor Group
Active
MedTechCzech Republic· 2025
DermaPharm
Active
HealthTechDenmark· 2025
Natus Sensory
Active
MedTechUS· 2022
PlasmidFactory
Active
BiotechGermany· 2022
Title21 Health Solutions
Active
HealthTechUS· 2022
Aliri
Active
PharmaUS· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings